IN RE AVANDIA MARKETING, SALES PRACTICES AND PRODUCTS LIABILITY LITIGATION MDL 1871 07-MD-01871
SMITHKLINE BEECHAM CORPORATION d/b/a GLAXOSMITHKLINE THIS DOCUMENT APPLIES TO: SHEILA SCHRANK on behalf of herself and all others similarly situated
MEMORANDUM OPINION AND ORDER
HON. CYNTHIA M. RUFE J.
The plaintiff in this case is a former user of the prescription diabetes drug Avandia. Plaintiff is not suing for physical injuries suffered as a result of taking Avandia; instead she seeks a refund of any monies she paid for Avandia (including insurance co-pays) and medical monitoring. Each type of relief is sought on behalf of a class of similarly situated individuals (the “Refund Class” and the “Monitoring Class, ” respectively), but no classes have been certified. The Court dismissed Plaintiff’s prior complaint with leave to amend, and Plaintiff has filed a Second Amended Complaint which the defendant, GlaxoSmithKline LLC (“GSK”), has moved to dismiss. The motion will be granted.
Plaintiff alleges that GSK promoted the use of Avandia to lower blood-sugar levels of patients with Type 2 diabetes. Plaintiff also alleges that taking Avandia significantly increases the patient’s chances of suffering a heart attack or susceptibility to other health risks, and that GSK concealed the risks of Avandia use while promoting the drug’s safety, efficacy, and effectiveness through a fraudulent and deceptive marketing program.
II. STANDARD OF REVIEW
Pursuant to Federal Rule of Civil Procedure 12(b)(6), dismissal of a complaint for failure to state a claim upon which relief can be granted is appropriate where a plaintiff’s “plain statement” lacks enough substance to show that he is entitled to relief. In determining whether a motion to dismiss should be granted, the court must consider only those facts alleged in the complaint, accepting the allegations as true and drawing all logical inferences in favor of the non-moving party. Courts are not, however, bound to accept as true legal conclusions couched as factual allegations. Something more than a mere possibility of a claim must be alleged; rather plaintiff must allege “enough facts to state a claim to relief that is plausible on its face.” The complaint must set forth “direct or inferential allegations respecting all the material elements necessary to sustain recovery under some viable legal theory.” The court has no duty to “conjure up unpleaded facts that might turn a frivolous . . . action into a substantial one.” Legal questions that depend upon a developed factual record are not properly the subject of a motion to dismiss.
Plaintiff proceeds under New York’s Consumer Protection Law,  which requires the plaintiff to allege that the defendant has engaged in a materially deceptive or misleading practice and that the plaintiff has been injured as a result. “[W]hile an assertion of justifiable reliance is not necessary, a plaintiff must allege that defendant’s consumer-oriented, deceptive acts or practices caused actual, although not necessarily pecuniary, harm directly to plaintiff.” “In interpreting this causation requirement, courts have held that where a plaintiff alleges that a defendant has engaged in deceptive advertising, but does not allege to have seen or been aware of such advertising, the plaintiff has not sufficiently pled a claim under [the statute] at the motion to dismiss stage.” The Court dismissed Plaintiff’s prior complaint, in part, because Plaintiff had failed to allege that she had seen any such advertising. In the Second Amended Complaint, Plaintiff alleges that in 2004 or 2005 she viewed advertisements featuring the singer Della Reese, which stated that if a “diabetes sufferer took Avandia, exercised and controlled his/her diet, that would help control the consumer-patient’s diabetes.” Plaintiff does not identify any affirmative misrepresentations about the risks of Avandia use in the advertisements, but does allege that the advertisements were misleading because they did not warn of the alleged dangers of Avandia use. However, although Plaintiff alleges that the commercials induced her to purchase Avandia, she does not allege when she began taking Avandia, or other facts from which the Court can infer a causal connection. Plaintiff also fails to allege that she paid more for Avandia than she would have paid for an alternative treatment. Plaintiff therefore has failed to allege facts to support a plausible claim that she was injured by the advertisements.
Plaintiff’s complaint fails to state any claim upon which relief can be granted. Because, despite having filed several complaints, Plaintiff has been unable to state a viable cause of action, further amendment would be inequitable and likely futile. The Second Amended Complaint therefore will be dismissed with prejudice. An appropriate order will be entered.
AND NOW, this 10th day of July 2013, upon consideration of Defendant’s Motion to Dismiss [Doc. No. 23; MDL Doc. No. 2011] and the response and replies thereto, it is hereby ORDERED that the Motion is GRANTED for the reasons set forth in the accompanying Memorandum Opinion. The Second Amended Complaint is ...